Nimeiri, H. S., Oza, A. M., Morgan, R. J., Friberg, G., Kasza, K., Faoro, L., . . . Fleming, G. F. (2008). Efficacy and Safety of Bevacizumab Plus Erlotinib for Patients with Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: A Trial of the Chicago, PMH, and California Phase II Consortia.
Citação norma ChicagoNimeiri, Halla S., et al. Efficacy and Safety of Bevacizumab Plus Erlotinib for Patients With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: A Trial of the Chicago, PMH, and California Phase II Consortia. 2008.
Citação norma MLANimeiri, Halla S., et al. Efficacy and Safety of Bevacizumab Plus Erlotinib for Patients With Recurrent Ovarian, Primary Peritoneal, and Fallopian Tube Cancer: A Trial of the Chicago, PMH, and California Phase II Consortia. 2008.